Recombinant Human UCHL1 Protein (rh UCHL1) Met 1 - Ala 223 (Accession # NP_004172) was produced in E.coli cells at ACROBiosystems.
rh UCHL1 is fused with a polyhistidine tag at the N-terminus, and has a calculated MW of 25.7 kDa. The predicted N-terminus is Met. DTT-reduced Protein migrates as 26 kDa in SDS-PAGE .
Less than 1.0 EU per μg of the rh UCHL1 by the LAL method.
>92% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in 20mM Tris, 500mM Nacl,1mM DTT,pH 8.0. Normally Mannitol or Trehalose are added as protectants before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4oC); After reconstitution under sterile conditions for 3 months (-70oC).
Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) ,a member of the peptidase C12 family, is also known as neuron cytoplasmic protein 9.5 (PGP 9.5) and ubiquitin thioesterase L1.About 30% of total UCHL1 is associated with membranes in brain. UCHL1 is involved both in the processing of ubiquitin precursors and of ubiquitinated proteins. This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. Also,UCHL1 can bind to free monoubiquitin and may prevent its degradation in lysosomes. The homodimer of UCHL1 may have ATP-independent ubiquitin ligase activity. Furthermore, the mutations of UCHL1 gene can result in parkinson disease 5.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.